Serum Vitamin D & Dry Eye Syndrome

Main Article Content

Shaveta .
Shah Nawaz


Introduction: Dry eye syndrome [DES] is one of the commonest ocular disorders characterized by tear film instability, visual discomfort & disturbance with ocular surface inflammation potentially leading to damage to the ocular surface. Serum Vitamin-D deficiency has been reported to be associated with DES.

Aim: To determine the Serum 25-hydroxy-vitamin-D levels in patients diagnosed as having DES.

Methods: We conducted a prospective observational study and included in our study, serum vitamin D levels of the first 40 patients over the age of 18 years presenting with signs and symptoms and later diagnosed to have DES [confirmed with ocular surface disease index-OSDI questionnaire, Schirmer I test, kerato-epitheliopathy examination and tear-film breakup time-[TBUT] were analysed.

Results: Schirmer's I test, interpreted as mild [11-15mm/5min], moderate [6-10 mm/5 min] and severe [<5mm/5min] had 8, 17 and 15 patients, respectively, with a mean value of 8 mm/5 min Schirmers I test. The minimum and maximum of Fluorescein TBUT measured in seconds was 4 and 10 seconds, respectively, with a mean of 6.2 seconds. Twenty four of our test subjects were found to have deficient Serum Vit 25[OH] D levels, nine had insufficient levels and seven had normal levels.

Conclusion: Vitamin D deficiency is prevalent in patient having DES.

Vitamin D deficiency, DES, OSDI, ocular disorders.

Article Details

How to Cite
., S., & Nawaz, S. (2019). Serum Vitamin D & Dry Eye Syndrome. Ophthalmology Research: An International Journal, 11(1), 1-4.
Original Research Article


Marshall LL, Roach JM. Treatment of dry eye disease. Consult Pharm. 2016;31(2): 96-106.

The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international dry eye workshop. Ocul Surf. 2007;5:75-92.

Yokoi N, Sonomura Y, Kato H, et al. Three per cent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry eye patients with Sjogrens Syndrome. Eye. 2015;29:1204-12.

Buchholz P, Steeds CS, Stern LS, Wiederkehr DP, Doyle JJ, Katz LM, et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf. 2006;4:155-61.

Barabino S, Chen Y, Chauhan S, Dana R. Dry eye disease: An immune mediated ocular surface disorder. Arch Ophthal. 2012;130:90-100

Vehof J, et al. Clinical characteristics of dry eye patients with chronic pain syndromes. Am J Ophthalmol. 2016;62:59-65.

Mencucci R, Boccalini C, Caputo R, Favuzza E. Effect of hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear film instability after cataract surgery. J Cataract Refract Surg. 2015;41:1699-1704.

Galo A, Gardener H, Pouyeh B, Feuer W, florez h. Effect of a Mediterranean dietary pattern and vitamin d levels on Dry Eye Syndrome. Cornea. 2014;33:437-41.

Muehleisen B, Gallo RL. Vitamin D in allergic disease: Shedding light on a complex problem. J allergy Clin Immunol. 2013;131:324-9.

Consiglio M, Viano M, Casarin S, Castagnoli C, Pescarmona G, Silvagno f. Mitochondrial and lipogenic effects of vitamin D in differentiating and proliferating human keratinocytes. Exp Dermatol; 2015.

Yoon SY, Bae SH, Shin YJ, Park SG, Hwang SH, Hyon JY, et al. Low serum 25-hydroxyvitamin D levels are associated with dry eye syndrome. PLoS One. 2016; 11(1).

Jeon DH, Yeom H, Yang J, Song JS, Lee HK, Kim HC. Are serum vitamin d levels associated with dry eye disease? Results from the study group for environmental eye disease. J Prev Med Public Health. 2017; 50:369-376.

Meng YF, et al. Lower serum Vitamin D level was associated with risk of dry eye syndrome. Med Sci Monit. 2017;23:2211-2216.

Kurtul BE, Ozer PA, Aydinli MS. The association of vitamin D deficiency with tear break up time and schirmer testing in non sjogren dry eye. Eye. 2015;29:1081-84.

Savini G, et al. The challenge of dry eye diagnosis. Clin Ophthalmol. 2008;2: 31-55.

Bae SH, et al. Vitamin D supplementation for patients with dry eye syndrome refractory to conventional treatment. Sci Rep. 6, 33083; 2016.
DOI: 10.1038/srep33083